Log in
NASDAQ:MCRB

Seres Therapeutics Price Target, Predictions & Analyst Ratings

$26.36
+1.11 (+4.40 %)
(As of 09/25/2020 12:00 AM ET)
Add
Compare
Today's Range
$25.03
Now: $26.36
$26.49
50-Day Range
$4.43
MA: $23.34
$27.33
52-Week Range
$2.52
Now: $26.36
$33.00
Volume586,717 shs
Average Volume1.26 million shs
Market Capitalization$2.01 billion
P/E RatioN/A
Dividend YieldN/A
Beta4.5

Analyst Ratings

Seres Therapeutics (NASDAQ:MCRB) Price Target and Consensus Rating

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
7 Wall Street analysts have issued ratings and price targets for Seres Therapeutics in the last 12 months. Their average twelve-month price target is $34.75, predicting that the stock has a possible upside of 31.83%. The high price target for MCRB is $42.00 and the low price target for MCRB is $27.50. There are currently 1 hold rating and 6 buy ratings for the stock, resulting in a consensus rating of "Buy."
Today30 Days Ago90 Days Ago180 Days Ago
MCRB Consensus Rating: BuyBuyBuyBuy
MCRB Consensus Rating Score: 2.863.002.672.83
MCRB Analyst Ratings: 0 Sell Rating(s)
1 Hold Rating(s)
6 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
7 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
2 Hold Rating(s)
4 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
1 Hold Rating(s)
5 Buy Rating(s)
0 Strong Buy Rating(s)
MCRB Consensus Price Target: $34.75$35.08$8.50$8.50
MCRB Price Target Upside: 31.83% upside34.11% upside79.70% upside129.73% upside

Seres Therapeutics (NASDAQ:MCRB) Consensus Price Target History

Average Share Price and Price Target by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.

Seres Therapeutics (NASDAQ:MCRB) Analyst Ratings History

Show:
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
9/21/2020Canaccord GenuityBoost Price TargetBuy$38.00 ➝ $42.00High
9/18/2020Chardan CapitalDowngradeBuy ➝ Neutral$32.50 ➝ $27.50Medium
9/13/2020OppenheimerReiterated RatingBuy$29.00High
8/18/2020Piper SandlerInitiated CoverageOverweight$40.00Medium
8/11/2020HC WainwrightBoost Price TargetBuy$8.00 ➝ $41.00High
8/11/2020Jefferies Financial GroupUpgradeHold ➝ Buy$4.00 ➝ $29.00High
11/4/2019CowenReiterated RatingBuyHigh
5/7/2019Cantor FitzgeraldReiterated RatingBuyHigh
8/3/2018Bank of AmericaDowngradeNeutral ➝ UnderperformHigh
10/13/2017CIBCInitiated CoverageOutperform ➝ Outperform$19.00N/A
10/12/2017CitigroupInitiated CoverageOutperform ➝ Positive$19.00N/A
10/6/2017Seaport Global SecuritiesReiterated RatingBuy$20.00N/A
(Data available from 9/27/2017 forward. View 10+ years of historical ratings with our analyst ratings screener.)
This page was last updated on 9/27/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.